Paper2011193
A mediator required for activation of RNA polymerase II transcription in vitro.
Flanagan PM and 4 others. Nature, 1991. Cited by 311 papers, by iCite.
Cite this record
ConductScience Library. A mediator required for activation of RNA polymerase II transcription in vitro. Papers, record 2011193. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2011193
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nuclear Proteins | Major topic |
| RNA Polymerase II | Major topic |
| Saccharomyces cerevisiae Proteins | Major topic |
| Transcription, Genetic | Major topic |
| DNA-Binding Proteins | |
| Enzyme Activation | |
| Fungal Proteins | |
| In Vitro Techniques | |
| Recombinant Proteins | |
| Saccharomyces cerevisiae | |
| Transcription Factor TFIID | |
| Transcription Factors |
Source PubMed
Cited by153
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 311 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42187732 | A Transcription Factor-Centric View of Transcription Regulation. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/42187732 | PubMed |
| 41425263 | A hypothetical model: Chromatin remodelers couple with acetyltransferases to trigger the elongation of RNA polymerase II (pol II). | Front Epigenet Epigenom | 2024 | https://conductscience.org/library/papers/41425263 | PubMed |
| 40940746 | The Mediator Complex: A Regulatory Hub for Transcriptional Activity of Nuclear Receptors. | Cells | 2025 | https://conductscience.org/library/papers/40940746 | PubMed |
| 40510693 | Differential regulation during development, aging, and disease implies heart cell specific functions of the Mediator Complex. | J Mol Cell Cardiol Plus | 2025 | https://conductscience.org/library/papers/40510693 | PubMed |
| 40201120 | BmMed6 modulates mating behavior by ORs and antennae structural genes in the silkworm. | iScience | 2025 | https://conductscience.org/library/papers/40201120 | PubMed |
| 40163908 | Cyclin-dependent kinases as mediators of aberrant transcription in prostate cancer. | Transl Oncol | 2025 | https://conductscience.org/library/papers/40163908 | PubMed |
| 39229005 | High-throughput affinity measurements of direct interactions between activation domains and co-activators. | bioRxiv | 2024 | https://conductscience.org/library/papers/39229005 | PubMed |
| 38690566 | Temporal regulation of the Mediator complex during muscle proliferation, differentiation, regeneration, aging, and disease. | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/38690566 | PubMed |
| 38684962 | RhMED15a-like, a subunit of the Mediator complex, is involved in the drought stress response in Rosa hybrida. | BMC Plant Biol | 2024 | https://conductscience.org/library/papers/38684962 | PubMed |
| 38321384 | Comparative phylogenetic analysis of the mediator complex subunit in asparagus bean (Vigna unguiculata ssp. sesquipedialis) and its expression profile under cold stress. | BMC Genomics | 2024 | https://conductscience.org/library/papers/38321384 | PubMed |
| 37446021 | Exploring the Role of Enhancer-Mediated Transcriptional Regulation in Precision Biology. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37446021 | PubMed |
| 36537119 | The Mediator complex subunit MED25 interacts with HDA9 and PIF4 to regulate thermomorphogenesis. | Plant Physiol | 2023 | https://conductscience.org/library/papers/36537119 | PubMed |
| 36180603 | Genomic regulation of transcription and RNA processing by the multitasking Integrator complex. | Nat Rev Mol Cell Biol | 2023 | https://conductscience.org/library/papers/36180603 | PubMed |
| 35385747 | Suppression of p53 response by targeting p53-Mediator binding with a stapled peptide. | Cell Rep | 2022 | https://conductscience.org/library/papers/35385747 | PubMed |
| 34414474 | Transcriptional enhancers and their communication with gene promoters. | Cell Mol Life Sci | 2021 | https://conductscience.org/library/papers/34414474 | PubMed |
| 34382181 | A Comprehensive Toolbox to Analyze Enhancer-Promoter Functions. | Methods Mol Biol | 2021 | https://conductscience.org/library/papers/34382181 | PubMed |
| 34197614 | Genome-wide CRISPR screens reveal cyclin C as synthetic survival target of BRCA2. | Nucleic Acids Res | 2021 | https://conductscience.org/library/papers/34197614 | PubMed |
| 34075876 | Repression by the Arabidopsis TOPLESS corepressor requires association with the core mediator complex. | Elife | 2021 | https://conductscience.org/library/papers/34075876 | PubMed |
| 33904398 | Simple biochemical features underlie transcriptional activation domain diversity and dynamic, fuzzy binding to Mediator. | Elife | 2021 | https://conductscience.org/library/papers/33904398 | PubMed |
| 33777083 | Mediator Subunits MED16, MED14, and MED2 Are Required for Activation of ABRE-Dependent Transcription in Arabidopsis. | Front Plant Sci | 2021 | https://conductscience.org/library/papers/33777083 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2011193
GET https://conductscience.org/api/papers/v1/2011193/cited_by?page=2